Prednisolone in early rheumatoid arthritis: an antiinvasive effect

Editorial

Edward D Harris Jr. Arthritis Rheum. 2005 Nov.

. 2005 Nov;52(11):3324-5.

doi: 10.1002/art.21422.

No abstract available

Comment in

The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by Harris.
Jacobs JW, Boers M, Kirwan JR, Bijlsma JW. Jacobs JW, et al. Arthritis Rheum. 2006 Jun;54(6):2031-2; author reply 2032. doi: 10.1002/art.22049. Arthritis Rheum. 2006. PMID: 16732571 No abstract available.

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Svensson B, et al. Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298. Arthritis Rheum. 2005. PMID: 16255010 Clinical Trial.
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
Wassenberg S, Rau R, Steinfeld P, Zeidler H. Wassenberg S, et al. Arthritis Rheum. 2005 Nov;52(11):3371-80. doi: 10.1002/art.21421. Arthritis Rheum. 2005. PMID: 16255011 Clinical Trial.